↓ Skip to main content

Dove Medical Press

Bone marrow mesenchymal stem cells as nuclear donors improve viability and health of cloned horses

Overview of attention for article published in Stem cells and cloning advances and applications, February 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
40 Mendeley
Title
Bone marrow mesenchymal stem cells as nuclear donors improve viability and health of cloned horses
Published in
Stem cells and cloning advances and applications, February 2018
DOI 10.2147/sccaa.s151763
Pubmed ID
Authors

R Olivera, LN Moro, R Jordan, N Pallarols, A Guglielminetti, C Luzzani, SG Miriuka, G Vichera

Abstract

Cell plasticity is crucial in cloning to allow an efficient nuclear reprogramming and healthy offspring. Hence, cells with high plasticity, such as multipotent mesenchymal stem cells (MSCs), may be a promising alternative for horse cloning. In this study, we evaluated the use of bone marrow-MSCs (BM-MSCs) as nuclear donors in horse cloning, and we compared the in vitro and in vivo embryo development with respect to fibroblasts. Zona-free nuclear transfer was performed using BM-MSCs (MSC group, n=3432) or adult fibroblasts (AF group, n=4527). Embryos produced by artificial insemination (AI) recovered by uterine flushing and transferred to recipient mares were used as controls (AI group). Blastocyst development was higher in the MSC group than in the AF group (18.1% vs 10.9%, respectively;p<0.05). However, pregnancy rates and delivery rates were similar in both cloning groups, although they were lower than in the AI group (pregnancy rates: 17.7% [41/232] for MSC, 12.5% [37/297] for AF and 80.7% [71/88] for AI; delivery rates: 56.8% [21/37], 41.5% [17/41] and 90.1% [64/71], respectively). Remarkably, the gestation length of the AF group was significantly longer than the control (361.7±10.9 vs 333.9±8.7 days), in contrast to the MSC group (340.6±8.89 days). Of the total deliveries, 95.2% (20/21) of the MSC-foals were viable, compared to 52.9% (9/17) of the AF-foals (p<0.05). In addition, the AF-foals had more physiological abnormalities at birth than the MSC-foals; 90.5% (19/21) of the MSC-delivered foals were completely normal and healthy, compared to 35.3% (6/17) in the AF group. The abnormalities included flexural or angular limb deformities, umbilical cord enlargement, placental alterations and signs of syndrome of neonatal maladjustment, which were treated in most cases. In summary, we obtained 29 viable cloned foals and found that MSCs are suitable donor cells in horse cloning. Even more, these cells could be more efficiently reprogrammed compared to fibroblasts.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 13%
Researcher 4 10%
Student > Master 4 10%
Student > Ph. D. Student 3 8%
Student > Postgraduate 3 8%
Other 4 10%
Unknown 17 43%
Readers by discipline Count As %
Agricultural and Biological Sciences 9 23%
Veterinary Science and Veterinary Medicine 8 20%
Biochemistry, Genetics and Molecular Biology 3 8%
Medicine and Dentistry 2 5%
Computer Science 1 3%
Other 1 3%
Unknown 16 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2018.
All research outputs
#16,725,651
of 25,382,440 outputs
Outputs from Stem cells and cloning advances and applications
#47
of 69 outputs
Outputs of similar age
#270,656
of 448,849 outputs
Outputs of similar age from Stem cells and cloning advances and applications
#2
of 2 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 69 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,849 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.